Netherlands· NL-2d5d23d32d7f

Cytomel 12,5 microgram, tabletten

A liothyronine sodium product containing liothyronine natrium, registered in Netherlands by ACE Pharmaceuticals B.V.. The same ATC class is registered in 5 of our 19 countries.

ATC H03AA02

Checked against CBG-MEB (Netherlands) on September 29, 2026

Informational only — not a medical device.

Compare price across countriesPer daily dose · free account Ask the assistant about liothyronine natriumAnswers with sources · free account Check interactionsSeverity free · mechanism on Growth

Where it is registered

Liothyronine sodium is registered in 5 of 19 countries.

Countries holding a registration under ATC H03AA02 (liothyronine sodium), each read from that country’s own register.

This record: Netherlands, from CBG-MEB (Netherlands)
2 of them publish a price we can compare per daily dose

Search liothyronine sodium products by name

Liothyronine sodium · ATC H03AA02

5 / 19 countries

Canada
Denmark
Netherlands
Norwayprice
United Statesprice

Blue: a registration under this ATC code. The ringed marker is this record’s country. Markets marked price publish a price we can compare per daily dose.

Price per daily dose

What a daily dose of liothyronine sodium costs, country by country.

Normalised to the WHO defined daily dose (60 mcg), so markets compare like for like.

1 market with a comparable price for this class
Public list prices, converted to USD at the rate date shown

Open the full comparison — free account Drug prices for market access

Liothyronine sodium · price per daily dose (60 mcg)

USD · FX 28 Sept 2026

US United States$0.71 (acquisition cost)

Median listed price per WHO defined daily dose, in each market that publishes a price. US = pharmacy acquisition cost (CMS NADAC), not a retail price. Open the full comparison

The record

At a glance

CBG-MEB (Netherlands)

Active substance: LIOTHYRONINE NATRIUM
Manufacturer: ACE Pharmaceuticals B.V.
Country: Netherlands (NL)
ATC code: H03AA02
ATC class: Liothyronine sodium
Defined daily dose: 60 mcg, O
Reimbursed: Not published by this register
Source register: CBG-MEB (Netherlands)
Last checked: September 29, 2026

Packs & prices · 1

cbg_meb_id
121884

Regulatory notes

No shortage, Orange Book or US label notes for this record.

Interactions

361 interactions on record for liothyronine sodium.

Graded by severity as the source publishes them — 177 moderate. Severity grades are free for everyone; mechanism and management come with Growth.

Severity for every pair — free, no plan needed
The source, licence and sync date on every record
Mechanism and what to do for each pair — Growth plan

Check liothyronine sodium against other medicines How interaction checks work

Liothyronine sodium · interactions on record

361 records

177 moderate
21 minor
163 info

Most severe, free to view

Magnesium carbonateA02AA01moderate
Magnesium oxideA02AA02moderate
Magnesium hydroxideA02AA04moderate
Kombinationen von AluminiumsalzenA02AB10moderate

Interaction severity from DDInter 2.0 (Xiong G. et al., Nucleic Acids Res.), licensed CC BY-NC 4.0 — free for non-commercial use only; not covered by the Drug Database commercial licence.

Mechanism and what to do, in the interaction check

Source: DDInter 2.0 · synced 29 Sept 2026. Grades as the source publishes them.

Same medicine, other countries

Liothyronine sodium in 9 other countries

What each register calls a product with the same active substance — salts and hydrates count as the same.

All liothyronine sodium products

Authorised across Europe · EMA

The same active substance is authorised in 8 EEA countries. Names it is sold under:

Germany · Thybon 100, Thybon 20
Denmark · Liopent
France · Cynomel, Thybon
United Kingdom (Northern Ireland) · Enolio, Iraksin
Greece · T3
Italy · Liotir
Norway · Liothyronin Orifarm Healthcare
Sweden · Liothyronin

Source: European Medicines Agency, Article 57 product data.

Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.

For developers

The same record over the API, and the raw payload

GET /v1/drugs/d14951b2-7fc8-4080-bbb9-a8dc8630e7bf
GET /v1/drugs/d14951b2-7fc8-4080-bbb9-a8dc8630e7bf?format=fhir

Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.

{
  "form": "Tablet",
  "route": "Oraal gebruik",
  "soort": "RVG",
  "source": "cbg_meb",
  "smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h121884_smpc.pdf",
  "strength": null,
  "atc_label": "Liothyronine Sodium",
  "detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg121884",
  "excipients": [
    "CALCIUMSULFAAT 2-WATER (E 516)",
    "CROSCARMELLOSE  NATRIUM  (E 468)",
    "GELATINE (E 441)",
    "MAGNESIUMSTEARAAT (E 470b)"
  ],
  "substances": [
    "LIOTHYRONINE NATRIUM"
  ],
  "leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h121884.pdf",
  "authorised_at": "2018/10/18",
  "procedure_number": null,
  "dispensing_status": "Uitsluitend recept",
  "registration_number": "121884",
  "additional_monitoring": "N"
}

API reference MCP server Plans

See everything about liothyronine sodium.

This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.

Try it free Open in the console